Page last updated: 2024-12-10

1-(2-(2-(4-pyridyl)-2-imidazoline-1-yl)ethyl)-3-(4-carboxyphenyl)urea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

You're asking about a specific chemical compound, **1-(2-(2-(4-pyridyl)-2-imidazoline-1-yl)ethyl)-3-(4-carboxyphenyl)urea**. This compound has a complex structure, suggesting it might have interesting biological properties. However, without further context, it's difficult to give you a definitive answer on its importance for research.

Here's what we can deduce:

* **Structure:** The name indicates a urea derivative containing multiple functional groups:
* **Urea:** A common functional group found in many biological molecules and pharmaceuticals.
* **4-pyridyl:** A pyridine ring, a heterocyclic compound frequently involved in interactions with biological targets.
* **Imidazoline:** A heterocyclic ring often found in pharmaceuticals.
* **Carboxyphenyl:** A benzene ring with a carboxylic acid group, which is often involved in binding to proteins.

**Possible research significance:**

Given the complexity of its structure, this compound could potentially be:

* **A drug candidate:** The presence of various pharmacophores (structural features that bind to biological targets) suggests it might exhibit biological activity. It could be a lead compound for developing new drugs for various conditions.
* **A probe molecule:** The unique structure could make it a useful tool for studying specific biological processes or interactions.
* **A building block for synthesis:** This compound could be used as a starting material to create other, potentially more valuable compounds.

**To determine its specific research significance, you need more information, including:**

* **What research field are you interested in?** The compound might be relevant to medicinal chemistry, drug discovery, biological chemistry, or other fields.
* **What are the specific research goals?** This will help narrow down the potential applications of the compound.
* **What are its biological properties?** This could include its affinity for specific receptors, its activity against enzymes or cells, or its toxicity profile.

**Where to find more information:**

* **Scientific databases:** Databases such as PubMed, Scopus, and SciFinder can help you find publications that mention this compound or related compounds.
* **Chemical suppliers:** Companies like Sigma-Aldrich or Thermo Fisher Scientific might sell this compound or provide information about its properties.
* **Research groups:** Contacting research groups specializing in drug discovery or related fields could provide insights into the relevance of this compound.

By searching for information related to this compound and its context, you can gain a deeper understanding of its potential research importance.

1-(2-(2-(4-pyridyl)-2-imidazoline-1-yl)ethyl)-3-(4-carboxyphenyl)urea: RN given refers to parent cpd; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3035698
CHEMBL ID475329
SCHEMBL ID3041459
MeSH IDM0103127

Synonyms (16)

Synonym
cgp 15720a
CHEMBL475329
cgp-15720
4-[2-(2-pyridin-4-yl-4,5-dihydroimidazol-1-yl)ethylcarbamoylamino]benzoic acid
73998-69-3
unii-3pvm978074
1-(2-(2-(4-pyridyl)-2-imidazoline-1-yl)ethyl)-3-(4-carboxyphenyl)urea
benzoic acid, 4-((((2-(4,5-dihydro-2-(4-pyridinyl)-1h-imidazol-1-yl)ethyl)amino)carbonyl)amino)-
3pvm978074 ,
cgp 15720 a
cgp 15720
SCHEMBL3041459
DTXSID00224784
1-{2-[2-(4-pyridyl)-2-imidazoline-1-yl]-ethyl]-3-(4-carboxy-phenyl)urea
Q27257878
PD159772

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In mice, single intraperitoneal dosage of 12 g/m2 did not produce lethality; however, lethality (30% of treated mice) was seen during treatment with 6 g/m2 daily for 5 days."( Prostatic atrophy in dogs after intravenous administration of a ureido-ethylimidazoline derivative (CGP15'720A).
Bullard, GA; Kanter, PM; Pavelic, ZP, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID409957Inhibition of bovine liver MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]